Meyka Pro banner
Veritas In Silico Inc.

Veritas In Silico Inc. (130A.T) Stock Overview

Explore Veritas In Silico Inc.’s financial performance, market position, analyst ratings, and future outlook.

130A.TJPX
HealthcareBiotechnology
¥430.00
¥2.00(0.47%)
Japanese Market opens in 10h 53m

Veritas In Silico Inc. (130A.T)

Meyka AI Score

Z

Key Financials

Market Cap2.9B
P/E RatioN/A
EPS (TTM)$-65.62
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

130A.T Stock Analysis & Investment Overview (JPX)

Our AI-powered analysis of Veritas In Silico Inc. (JPX: 130A.T) gives investors deep insight into how the stock performs on the JPX exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Veritas In Silico Inc.'s JPX-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of 130A.T on the JPX shows an RSI of 66.79, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $N/A for the JPX listing.

Key metrics behind Veritas In Silico Inc.'s JPX-traded stock include a P/E ratio of N/A and a market capitalization of 2.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of 130A.T on the JPX.

Price Performance (JPX: 130A.T)

1-Day Change
4.91%
5-Day Change
3.94%
1-Month Change
7.67%
3-Month Change
15.13%
6-Month Change
-5.87%
Year-to-Date (YTD) Change
-5.47%
1-Year Change
-37.73%
3-Year Change
-82.05%
5-Year Change
-82.05%
All-Time (Max) Change
-82.05%

Contact Information

NaN
1-11-1 Nishigotanda, Tokyo, TY, 141-0031

Company Facts

190 Employees
IPO DateFeb 8, 2024
CountryJP
Actively Trading

Frequently Asked Questions